PVH
52
-3
MDLZ
34
2
MS
74
-2
USB
50
2
EXR
57
-2
CAH
47
3
ED
48
3
TGNA
53
2
SCHW
64
2
MKC
56
8
PSA
51
-4
ILMN
32
-3
M
20
-4
INTU
51
2
DE
46
3
ZTS
47
2
NRG
49
-3
JNPR
46
3
EIX
77
2
KMX
58
3
PVH
52
-3
MDLZ
34
2
MS
74
-2
USB
50
2
EXR
57
-2
CAH
47
3
ED
48
3
TGNA
53
2
SCHW
64
2
MKC
56
8
PSA
51
-4
ILMN
32
-3
M
20
-4
INTU
51
2
DE
46
3
ZTS
47
2
NRG
49
-3
JNPR
46
3
EIX
77
2
KMX
58
3
Financhill
Back

Theriva Biologics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

TOVX
Theriva Biologics

Last Price:
1.26
Seasonality Move:
98.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Theriva Biologics Price Quote

$1.26

Theriva Biologics Key Stats

Sell
42
Theriva Biologics (TOVX) is a Sell
Day range:
$1.25 - $1.32
52-week range:
$1.24 - $17.11
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.14%
Volume:
57.4K
Avg. volume:
3.2M
1-year change:
-88.8%
Market cap:
$3.5M
Revenue:
$0
EPS:
$-33.18

How Much Does Theriva Biologics Make?

Data Unavailable

Is Theriva Biologics Growing As A Company?

Data Unavailable

Theriva Biologics Stock Price Performance

  • Did Theriva Biologics Stock Go Up Last Month?
    Theriva Biologics share price went down by -15.44% last month
  • Did TOVX's Share Price Rise Over The Last Year?
    TOVX share price fell by -88.8% over the past 1 year

What Is Theriva Biologics 52-Week High & Low?

Theriva Biologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Theriva Biologics?

  • How Much Debt Does Theriva Biologics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Theriva Biologics Have?
    Cash and short term investments quarterly total is $16.4M
  • What Is Theriva Biologics’s Book Value Per Share?
    Book value per share is 9.41

Is Theriva Biologics Cash Flow Positive?

  • What Is TOVX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$18.8M
  • What Is Theriva Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4M
  • What Is Theriva Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$57K

Theriva Biologics Return On Invested Capital

Data Unavailable

Theriva Biologics Earnings Date & Stock Price

Theriva Biologics Competitors

  • Who Are Theriva Biologics's Competitors?
    Below is a list of companies who compete with Theriva Biologics or are related in some way:
    • BioCardia Inc (BCDA)
    • Merck & Co Inc (MRK)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Pro-Dex Inc (PDEX)
    • Palatin Technologies Inc (PTN)

Theriva Biologics Dividend Yield

Theriva Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -29.71%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 90.50
Upside from Last Price: 7082.54%

Major Shareholders

  • How many TOVX shares are owned by institutional investors?
    1.3M TOVX shares are owned by institutional investors
  • How many TOVX shares are owned by insiders?
    6.6M TOVX shares are owned by insiders